碘化直肠间隔物在前列腺光子与质子放疗中的特性研究
本研究对比了碘化直肠间隔物(I-SP)与传统间隔物(nonI-SP)在前列腺癌放疗中的放置、稳定性及计划质量。I-SP在计划CT上呈现明显高对比度(HU 138 vs 12,P < .001),可单独用于勾画而无需MRI。I-SP的体积和表面积较小,但相对位置及前列腺-直肠间距相似,且在整个疗程中保持稳定,计划质量与稳健性无显著差异。
要点
- I-SP在CT上HU值显著高于nonI-SP(138 vs 12,P < .001),可独立勾画。
- I-SP体积和表面积小于nonI-SP,但位置和间距相似。
- I-SP在28至44次治疗中HU、体积、位置稳定,计划质量无差异。
核心结论
- I-SP提供明显的CT对比度,可单独在计划CT上勾画而无需MRI。
- I-SP的影像学特性、大小和相对位置在整个疗程中保持稳定。
- I-SP与nonI-SP相比,计划质量和稳健性无显著变化。
研究设计与样本
- 研究纳入50例接受光子放疗的I-SP患者,与随机选取的50例nonI-SP患者(光子或质子治疗)进行比较。
- 在计划CT上勾画I-SP,并在首次、中间和末次治疗时于锥形束CT上勾画(共200次扫描)。
- 比较计划CT上I-SP的HU值、体积、表面积、质心位置及前列腺-直肠质心距离。
- 通过体模测试I-SP对质子的相对线性停止本领。
主要发现
- I-SP在计划CT上HU值为138,nonI-SP为12(P < .001)。
- I-SP勾画体积为8.9 mL,nonI-SP为10.6 mL(P < .001);表面积分别为28 cm2和35 cm2(P < .001)。
- 相对间隔物位置和前列腺-直肠分离度相似(P = .79)。
- I-SP水凝胶的HU、体积、表面积或相对位置在整个疗程中无显著变化(所有P > .1)。
- I-SP相对线性停止本领为1.018,质子计划需进行HU覆盖。
关键数值与推荐
- I-SP在CT上HU值138 vs nonI-SP 12,P < .001。
- I-SP体积8.9 mL vs nonI-SP 10.6 mL,P < .001;表面积28 cm2 vs 35 cm2,P < .001。
- 相对位置和前列腺-直肠分离度相似,P = .79。
- I-SP特性在整个疗程中无显著变化,所有P > .1。
- I-SP相对线性停止本领1.018,质子计划需HU覆盖。
临床怎么用
- I-SP可用于计划CT单独勾画,避免MRI检查。
- I-SP在光子放疗中计划质量与nonI-SP相当。
- 质子放疗中使用I-SP需进行HU覆盖以校正停止本领。
局限性
- 研究为回顾性比较,样本量有限(每组50例)。
- 未报告长期临床结局或毒性数据。
- 体模测试结果需临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Conventional rectal spacers (nonI-SPs) are low-contrast on computed tomography (CT), often necessitating magnetic resonance imaging for accurate delineation. A new formulation of spacers (I-SPs) incorporates iodine to improve radiopacity and CT visualization. We characterized placement, stability, and plan quality of I-SPs compared to nonI-SPs. METHODS AND MATERIALS: Patients with intact prostate cancer (n = 50) treated with I-SPs and photons were compared to randomly selected patients (n = 50) with nonI-SPs (photon or proton therapy). The I-SP was contoured on the planning CT and cone beam CTs at 3 timepoints: first, middle, and final treatment (n = 200 scans). I-SPs Hounsfield units (HU), volume, surface area (SA), centroid position relative to prostate centroid, and distance between prostate/rectum centroids were compared on the planning CTs between each cohort. I-SP changes were evaluated on cone beam CTs over courses of treatment. Dosimetric evaluations of plan quality and robustness were performed. I-SP was tested in a phantom to characterize its relative linear stopping power for protons. RESULTS: I-SPs yielded a distinct visible contrast on planning CTs compared to nonI-SPs (HU 138 vs 12, P < .001), allowing delineation on CT alone. The delineated volume and SA of I-SPs were smaller than nonI-SPs (volume 8.9 vs 10.6 mL, P < .001; SA 28 vs 35 cm2, P < .001), yet relative spacer position and prostate-rectal separation were similar (P = .79). No significant change in HU, volume, SA, or relative position of the I-SPs hydrogel occurred over courses of treatment (all P > .1). Dosimetric analysis concluded there were no significant changes in plan quality or robustness for I-SPs compared to nonI-SPs. The I-SP relative linear stopping power was 1.018, necessitating HU override for proton planning. CONCLUSIONS: I-SPs provide a manifest CT contrast, allowing for delineation on planning CT alone with no magnetic resonance imaging necessary. I-SPs radiopacity, size, and relative position remained stable over courses of treatment from 28 to 44 fractions. No changes in plan quality or robustness were seen comparing I-SPs and nonI-SPs.
引用
- Kamran SC, McClatchy DM, Pursley J, et al. Characterization of an Iodinated Rectal Spacer for Prostate Photon and Proton Radiation Therapy. Pract Radiat Oncol. 2021. PMID: 34619374. doi:10.1016/j.prro.2021.09.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。